Abstract:Loss-of-function mutations in the Notch ligand, Jagged1 (Jag1), result in multi-system developmental pathologies associated with Alagille syndrome (ALGS). ALGS patients present with skeletal manifestations including hemi-vertebrae, reduced bone mass, increased fracture incidence and poor bone healing. However, it is not known whether the increased fracture risk is due to altered bone homeostasis (primary) or nutritional malabsorption due to chronic liver disease (secondary). To determine the significance of Jag1 loss in bone, we characterized the skeletal phenotype of two Jag1-floxed conditional knockout mouse models: Prx1-Cre;Jag1(f/f) to target osteoprogenitor cells and their progeny, and Col2.3-Cre;Jag1(f/f) to target mid-stage osteoblasts and their progeny. Knockout phenotypes were compared to wild-type (WT) controls using quantitative micro-computed tomography, gene expression profiling and mechanical testing. Expression of Jag1 and the Notch target genes Hes1 and Hey1 was downregulated in all Jag1 knockout mice. Osteoblast differentiation genes were downregulated in whole bone of both groups, but unchanged in Prx1-Cre;Jag1(f/f) cortical bone. Both knockout lines exhibited changes in femoral trabecular morphology including decreased bone volume fraction and increased trabecular spacing, with males presenting a more severe trabecular osteopenic phenotype. Prx1-Cre;Jag1(f/f) mice showed an increase in marrow mesenchymal progenitor cell number and, counterintuitively, developed increased cortical thickness resulting from periosteal expansion, translating to greater mechanical stiffness and strength. Similar alterations in femoral morphology were observed in mice with canonical Notch signaling disrupted using Prx1-Cre-regulatable dominant-negative mastermind like-protein (dnMAML). Taken together, we report that 1) Jag1 negatively regulates the marrow osteochondral progenitor pool, 2) Jag1 is required for normal trabecular bone formation and 3) Notch signaling through homotypic Jag1 signaling in osteochondral progenitors, but not mature osteoblasts, inhibits periosteal expansion. Therefore, Jag1 signaling within the osteoblast lineage regulates bone metabolism in a compartment-dependent manner. Moreover, loss of Jag1 function in osteoblast lineage cells may contribute to the skeletal phenotype associated with ALGS.

Jag1 insufficiency alters liver fibrosis via T cell and hepatocyte differentiation defects

Jag1 Insufficiency Disrupts Neonatal T Cell Differentiation and Impairs Hepatocyte Maturation, Leading to Altered Liver Fibrosis

Jagged-mediated development and disease: Mechanistic insights and therapeutic implications for Alagille syndrome

Alagille Syndrome is Caused by Mutations in Human Jagged1, Which Encodes A Ligand for Notch1

Targeted Sequencing and RNA Assay Reveal a Noncanonical JAG1 Splicing Variant Causing Alagille Syndrome.

Intrahepatic cholangiocyte regeneration from an Fgf‐dependent extrahepatic progenitor niche in a zebrafish model of Alagille Syndrome

Conditional JAG1 Mutation Shows the Developing Heart is More Sensitive Than Developing Liver to JAG1 Dosage

Dll4 and Jagged-1 improve liver fibrosis dependent of etiology

Bleeding in patients and mice with Alagille syndrome: sex differences and risk factors

Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice

[Identification of a Novel JAG1 Mutation in a Family Affected by Alagille Syndrome].

Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis

Mutation Analysis of Jagged1 (JAG1) in Alagille Syndrome Patients Communicated by Ian McIntosh Online Citation: Human Mutation, Mutation in Brief #397 (2000) Online Http://Journals.wiley.com/1059-7794/Pdf/mutation/397.pdf

Biglycan promotes hepatic fibrosis through activating heat shock protein 47

Notch signaling participates in liver fibrosis

Jag1 represses Notch activation in lateral supporting cells and inhibits an outer hair cell fate in the medial cochlea

De Novo Jag1 Gene Deletion Causes Atypical Severe Alagille Syndrome In A Chinese Child

Analysis of JAG1 Gene Variant in Chinese Patients with Alagille Syndrome.

Processing of angiocrine alarmin IL-1α in endothelial cells promotes lung and liver fibrosis

Novel JAG1 variants leading to Alagille syndrome in two Chinese cases

ATG16L1 Depletion-Mediated Activation of the TRAF1 Signaling in Macrophages Aggravates Liver Fibrosis